Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
One-stage hybrid coronary revascularization for the treatment of multivessel coronary artery disease- Periprocedural and long-term results from the "HYBRID-COR" feasibility study.
Sanetra K, Buszman PP, Jankowska-Sanetra J, Cisowski M, Fil W, Gorycki B, Bochenek A, Slabon-Turska M, Konopko M, Kaźmierczak P, Gerber W, Milewski K, Buszman PE. Sanetra K, et al. Among authors: fil w. Front Cardiovasc Med. 2022 Oct 19;9:1016255. doi: 10.3389/fcvm.2022.1016255. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36337903 Free PMC article.
Long‑term outcomes of transcatheter self-expanding aortic valve implantations in inoperable and high surgical-risk patients with severe aortic stenosis: a single-center single-valve registry.
Dębiński M, Domaradzki W, Fil W, Milewski K, Buszman PP, Kachel M, Brączkowski J, Gerber W, Cisowski M, Bochenek A, Zejda JE, Buszman PE. Dębiński M, et al. Among authors: fil w. Kardiol Pol. 2021 Mar 25;79(3):319-326. doi: 10.33963/KP.15821. Epub 2021 Feb 17. Kardiol Pol. 2021. PMID: 33599461 Free article.
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke.
Whitlock RP, Belley-Cote EP, Paparella D, Healey JS, Brady K, Sharma M, Reents W, Budera P, Baddour AJ, Fila P, Devereaux PJ, Bogachev-Prokophiev A, Boening A, Teoh KHT, Tagarakis GI, Slaughter MS, Royse AG, McGuinness S, Alings M, Punjabi PP, Mazer CD, Folkeringa RJ, Colli A, Avezum Á, Nakamya J, Balasubramanian K, Vincent J, Voisine P, Lamy A, Yusuf S, Connolly SJ; LAAOS III Investigators. Whitlock RP, et al. N Engl J Med. 2021 Jun 3;384(22):2081-2091. doi: 10.1056/NEJMoa2101897. Epub 2021 May 15. N Engl J Med. 2021. PMID: 33999547 Clinical Trial.
Transcatheter aortic valve‑in‑valve implantation for failed surgical bioprostheses: results from the Polish Transcatheter Aortic Valve-in-Valve Implantation (ViV‑TAVI) Registry.
Huczek Z, Jędrzejczyk S, Jagielak D, Dąbrowski M, Grygier M, Gruz-Kwapisz M, Fil W, Olszówka P, Frank M, Wilczek K, Walczak A, Trębacz J, Telichowski A, Protasiewicz M, Sacha J, Rymuza B, Grodecki K, Scisło P, Hudziak D, Gocoł R, Zembala M, Wilimski R, Kochman J, Witkowski A, Wojakowski W. Huczek Z, et al. Among authors: fil w. Pol Arch Intern Med. 2022 Feb 28;132(2):16149. doi: 10.20452/pamw.16149. Epub 2021 Nov 30. Pol Arch Intern Med. 2022. PMID: 34845900 Free article.
Transcatheter aortic valve-in-valve implantation in failed stentless bioprostheses.
Huczek Z, Grodecki K, Scisło P, Wilczek K, Jagielak D, Fil W, Kubler P, Olszówka P, Dąbrowski M, Frank M, Grygier M, Kidawa M, Wilimski R, Żelazowska K, Witkowski A, Kochman J, Zembala M, Opolski G, Dvir D, Wojakowski W. Huczek Z, et al. Among authors: fil w. J Interv Cardiol. 2018 Dec;31(6):861-869. doi: 10.1111/joic.12540. Epub 2018 Jul 15. J Interv Cardiol. 2018. PMID: 30009390 Free article.
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, Jamal W, Kimura K, Schnee J, Zeller C, Cotton D, Bocchi E, Böhm M, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Janssens S, Zhang J, Gonzalez Juanatey JR, Kaul S, Brunner-La Rocca HP, Merkely B, Nicholls SJ, Perrone S, Pina I, Ponikowski P, Sattar N, Senni M, Seronde MF, Spinar J, Squire I, Taddei S, Wanner C, Zannad F; EMPEROR-Reduced Trial Investigators. Packer M, et al. N Engl J Med. 2020 Oct 8;383(15):1413-1424. doi: 10.1056/NEJMoa2022190. Epub 2020 Aug 28. N Engl J Med. 2020. PMID: 32865377 Free article. Clinical Trial.
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.
Verma S, Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Peil B, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Reduced trial committees and investigators. Verma S, et al. Lancet Diabetes Endocrinol. 2022 Jan;10(1):35-45. doi: 10.1016/S2213-8587(21)00292-8. Epub 2021 Nov 30. Lancet Diabetes Endocrinol. 2022. PMID: 34861154
16 results